Wednesday, February 10, 2010, 1:12am EST - Canadian Markets open in 8 hours and 18 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Covidien, Ltd. (COV)

 On Feb 9: 49.55 USD  Up 0.09 (0.18%)  
MORE ON COV
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
COVIDIEN PLC (NYSE:COV) Delayed quote dataEdit
After Hours: 49.61 Up 0.06 (0.12%) as of 4:16pm EST on 02/09/10
Last Trade: 49.55 USD
Trade Time: Feb 9
Change: Up 0.09 (0.18%)
Prev Close: 49.46
Open: 49.44
Bid: N/A
Ask: N/A
1y Target Est: 49.29
Day's Range: 49.30 - 49.99
52wk Range: 27.27 - 52.40
Volume: 2,326,425
Avg Vol (3m): 2,644,120
Market Cap: 24.79B
P/E (ttm): N/A
EPS (ttm): -0.69
Div & Yield: 0.68 (1.37%)
Covidien, Ltd. (COV)
1d  5d  3m  6m  1y  2y  5y 
Free Annual Reports
 Add COV to Portfolio   Download Data

HEADLINES
• Stocks: How Investors Might Play the Pullback
at BusinessWeek (Mon, Feb 8)
• Cramer's Stop Trading! I See No Courage Out There (2/5/10)
at Seeking Alpha (Sun, Feb 7)
• Cramer: What Wall Street Is Missing
at CNBC (Fri, Feb 5)
• Cramer's 'Stop Trading': Covidien Dividend
at TheStreet.com (Fri, Feb 5)
• COVIDIEN PLC Financials
EDGAR Online Financials (Sat, Jan 30)
• Lightning Round OT: EMC, PPL and More
at CNBC (Wed, Jan 27)
• Covidien Ltd.: Warming Up or Cooling Off?
at Motley Fool (Wed, Jan 27)
• COVIDIEN PLC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, Jan 26)
• Cramer 's Mad Money - 5 Investment Ideas for the New Bernanke Era (1/25/10)
at Seeking Alpha (Tue, Jan 26)
• Cramer: Washington's Next Assault
at CNBC (Mon, Jan 25)
• Cramer's 'Mad Money' Recap: Guarding Against Another Assault From Washington (Update 3)
at TheStreet.com (Mon, Jan 25)
• Cramer's 'Mad Money' Follow-Up: Jan. 25
at TheStreet.com (Mon, Jan 25)
More Headlines for COV...
ANALYST
EPS Est (next year) (Sep-08) : 2.49
EPS Est (in 2 years) (Sep-09) : 2.83
Avg Rec (current)*: 2.3
PEG Ratio: 3.98
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Covidien, Ltd. engages in the development, manufacture, and sale of healthcare products for use in clinical and home settings worldwide. It operates through five segments: Medical Devices, Pharmaceutical Products, Imaging Solutions, Medical Suppli...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices